Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA for Adults with IBS-C, to be Presented at the 2023 Digestive Disease Week Conference - Marketscreener.com
| KHTRF Stock | USD 3.73 0.02 0.53% |
Roughly 62% of Knight Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Knight Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Knight Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Knight Therapeutics stock news signals to limit their universe of possible portfolio assets.
Knight Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Knight daily returns and investor perception about the current price of Knight Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Knight |
Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA for Adults with IBS-C, to be Presented at the 2023 Digestive Disease Week Conference Marketscreener.com
Read at news.google.com
 |
Knight Therapeutics Fundamental Analysis
We analyze Knight Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Knight Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Knight Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Knight Therapeutics is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Knight Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Knight Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Knight Therapeutics could also be used in its relative valuation, which is a method of valuing Knight Therapeutics by comparing valuation metrics with similar companies.
Peers
Knight Therapeutics Related Equities
| BINP | Bionoid Pharma | 8.00 | ||||
| CRRTF | Crescita Therapeutics | 0.00 | ||||
| HLTRF | HLS Therapeutics | 1.64 | ||||
| LOVFF | Cannara Biotech | 9.09 |
Complementary Tools for Knight Pink Sheet analysis
When running Knight Therapeutics' price analysis, check to measure Knight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Knight Therapeutics is operating at the current time. Most of Knight Therapeutics' value examination focuses on studying past and present price action to predict the probability of Knight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Knight Therapeutics' price. Additionally, you may evaluate how the addition of Knight Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |